ADAGIO THERAPEUTICS INC (ADGI)
US00534A1025 - Common Stock
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash Equivalents | 474.88M | 542.22M | 114.99M | |||
| Marketable Securities | 0.00 | 49.19M | N/A | |||
| Other Current Assets | 6.48M | 25.29M | 2.39M | |||
| Total Current Assets | 481.36M | 616.71M | 117.38M | |||
| Non-Current Assets | ||||||
| PPE Net | 2.95M | 83.00K | N/A | |||
| Other Non-Current Assets | 299.00K | 3.30M | N/A | |||
| Total Non-Current Assets | 3.25M | 3.38M | 0.00 | |||
| TOTAL ASSETS | 484.61M | 620.09M | 117.38M | |||
| LIABILITIES | ||||||
| Current Liabilities | ||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 53.59M | 56.28M | 4.92M | |||
| Accounts Payable | 14.23M | 5.78M | 8.15M | |||
| Other Current Liabilities | 58.00K | N/A | N/A | |||
| Total Current Liabilities | 67.88M | 62.06M | 13.07M | |||
| Non-Current Liabilities | ||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.89M | 12.00K | 11.00K | |||
| Total Non-Current Liabilities | 1.89M | 12.00K | 11.00K | |||
| TOTAL LIABILITIES | 69.77M | 62.07M | 13.08M | |||
| SHAREHOLDERS' EQUITY | ||||||
| Retained Earnings | -443.76M | -292.11M | -65.32M | |||
| Additional Paid In Capital | 858.59M | 850.13M | 155.00K | |||
| Common Shares | 11.00K | 11.00K | 169.55M | |||
| Treasury Stock | 0.00 | N/A | -85.00K | |||
| Other Shareholders' Equity | 0.00 | -8.00K | N/A | |||
| Shares Outstanding | 108.78M | 110.78M | 108.52M | |||
| Tangible Book Value per Share | 3.81 | 5.04 | -0.60 | |||
| Total Shareholders' Equity | 414.84M | 558.02M | 104.30M | |||
| TOTAL LIABILITIES AND EQUITY | 484.61M | 620.09M | 117.38M | |||
| Statistics | ||||||
| Current Ratio | 7.09 | 9.94 | 8.98 | |||
| Return On Assets (ROA) | -60.89% | -36.57% | -55.65% | |||
| Return On Equity (ROE) | -71.13% | -40.64% | -62.63% | |||
All data in USD